TY - JFULL ID - 119257633 TI - Expert review of precision medicine and drug development. PY - 2016 SN - 23808993 PB - Abingdon, Oxon, UK : Taylor & Francis Group, DB - UniCat KW - Personalized medicine KW - Drug development KW - Pharmacogenetics KW - Biochemical markers KW - Precision Medicine. KW - Biomarkers KW - Drug Design. KW - Clinical Laboratory Techniques KW - Pharmacogenetics. KW - Biochemical markers. KW - Drug development. KW - Personalized medicine. KW - analysis. KW - standards. KW - Pharmacology KW - Biochemical genetics KW - Individualized medicine KW - Medical care KW - Development of drugs KW - Drugs KW - New drug development KW - Pharmacy KW - Biologic markers KW - Biological markers KW - Markers, Biochemical KW - Biochemistry KW - Indicators (Biology) KW - Pharmacogenomics KW - Pharmacogenomic Variants KW - Drug Resistance KW - Toxicology KW - Precision Medicine KW - Computer-Aided Drug Design KW - Computerized Drug Design KW - Drug Modeling KW - Pharmaceutical Design KW - Computer Aided Drug Design KW - Computer-Aided Drug Designs KW - Computerized Drug Designs KW - Design, Pharmaceutical KW - Drug Design, Computer-Aided KW - Drug Design, Computerized KW - Drug Designs KW - Drug Modelings KW - Pharmaceutical Designs KW - P Health KW - P-Health KW - Personalized Medicine KW - Theranostics KW - Individualized Medicine KW - Predictive Medicine KW - Medicine, Individualized KW - Medicine, Personalized KW - Medicine, Precision KW - Medicine, Predictive KW - Theranostic KW - Patient-Specific Modeling KW - Genetic aspects KW - Development KW - Precision medicine KW - Precision medicine. KW - Médecine de précision KW - Médicaments KW - Pharmacogénétique KW - Marqueurs biologiques KW - Développement UR - https://www.unicat.be/uniCat?func=search&query=sysid:119257633 AB - ER -